Berlin - Delayed Quote • EUR
Alnylam Pharmaceuticals Inc (DUL.BE)
As of 4:58 PM GMT+2. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
3,829,880.00
3,546,359.00
3,643,304.00
3,407,061.00
Total Liabilities Net Minority Interest
4,050,524.00
3,704,582.00
3,055,101.00
2,390,814.00
Total Equity Gross Minority Interest
-220,644.00
-158,223.00
588,203.00
1,016,247.00
Total Capitalization
800,132.00
858,719.00
1,263,900.00
1,207,525.00
Common Stock Equity
-220,644.00
-158,223.00
588,203.00
1,016,247.00
Capital Lease Obligations
284,611.00
303,306.00
321,895.00
329,911.00
Net Tangible Assets
-220,644.00
-158,223.00
588,203.00
1,016,247.00
Working Capital
2,014,911.00
1,924,332.00
2,112,866.00
2,029,507.00
Invested Capital
800,132.00
858,719.00
1,263,900.00
1,207,525.00
Tangible Book Value
-220,644.00
-158,223.00
588,203.00
1,016,247.00
Total Debt
1,305,387.00
1,320,248.00
997,592.00
521,189.00
Net Debt
208,088.00
150,548.00
--
--
Share Issued
125,794.00
123,925.00
120,182.00
116,427.00
Ordinary Shares Number
125,794.00
123,925.00
120,182.00
116,427.00
12/31/2020 - 8/11/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade